Abstract
The acute treatment and preventive therapy of migraine seems to have come to a halt recently. The last real innovation in the treatment of migraine attacks were the triptans, which were introduced 20 years ago. The last new drug for the prevention of episodic migraine was topiramate, which is now off-patent. Therefore, it is time to explore new avenues in the treatment of migraine. This book describes new approaches to the treatment of acute migraine attacks and to migraine prevention. Beyond new drugs and drug targets, we show advances in nonmedical treatments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
